img

Global Ranibizumab Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ranibizumab Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.
Ranibizumab report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ranibizumab market is projected to reach US$ 1647.3 million in 2034, increasing from US$ 3449.6 million in 2022, with the CAGR of -9.9% during the period of 2024 to 2034. Demand from Wet AMD and Complications of Diabetes are the major drivers for the industry.
Global core ranibizumab manufacturers include Roche and Novartis etc. The Top 2 companies hold a share about 98%. North America is the largest market, with a share about 51%, followed by Europe and Asia Pacific with the share about 28% and 20%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ranibizumab market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche
Novartis
Segment by Type
Glass Vial
Prefilled Syringe

Segment by Application


Wet AMD
Complications of Diabetes
RVO
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ranibizumab market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Ranibizumab introduction, etc. Ranibizumab Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Ranibizumab market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Ranibizumab
1.1 Ranibizumab Market Overview
1.1.1 Ranibizumab Product Scope
1.1.2 Ranibizumab Market Status and Outlook
1.2 Global Ranibizumab Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Ranibizumab Market Size by Region (2018-2034)
1.4 Global Ranibizumab Historic Market Size by Region (2018-2024)
1.5 Global Ranibizumab Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Ranibizumab Market Size (2018-2034)
1.6.1 North America Ranibizumab Market Size (2018-2034)
1.6.2 Europe Ranibizumab Market Size (2018-2034)
1.6.3 Asia-Pacific Ranibizumab Market Size (2018-2034)
1.6.4 Latin America Ranibizumab Market Size (2018-2034)
1.6.5 Middle East & Africa Ranibizumab Market Size (2018-2034)
2 Ranibizumab Market by Type
2.1 Introduction
2.1.1 Glass Vial
2.1.2 Prefilled Syringe
2.2 Global Ranibizumab Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Ranibizumab Historic Market Size by Type (2018-2024)
2.2.2 Global Ranibizumab Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Ranibizumab Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Ranibizumab Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Ranibizumab Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Ranibizumab Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Ranibizumab Revenue Breakdown by Type (2018-2034)
3 Ranibizumab Market Overview by Application
3.1 Introduction
3.1.1 Wet AMD
3.1.2 Complications of Diabetes
3.1.3 RVO
3.1.4 Others
3.2 Global Ranibizumab Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Ranibizumab Historic Market Size by Application (2018-2024)
3.2.2 Global Ranibizumab Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Ranibizumab Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Ranibizumab Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Ranibizumab Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Ranibizumab Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Ranibizumab Revenue Breakdown by Application (2018-2034)
4 Ranibizumab Competition Analysis by Players
4.1 Global Ranibizumab Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ranibizumab as of 2022)
4.3 Date of Key Players Enter into Ranibizumab Market
4.4 Global Top Players Ranibizumab Headquarters and Area Served
4.5 Key Players Ranibizumab Product Solution and Service
4.6 Competitive Status
4.6.1 Ranibizumab Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Ranibizumab Products, Services and Solutions
5.1.4 Roche Ranibizumab Revenue (US$ Million) & (2018-2024)
5.1.5 Roche Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Ranibizumab Products, Services and Solutions
5.2.4 Novartis Ranibizumab Revenue (US$ Million) & (2018-2024)
5.2.5 Novartis Recent Developments
6 North America
6.1 North America Ranibizumab Market Size by Country (2018-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Ranibizumab Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Ranibizumab Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Ranibizumab Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Ranibizumab Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Ranibizumab Market Dynamics
11.1 Ranibizumab Industry Trends
11.2 Ranibizumab Market Drivers
11.3 Ranibizumab Market Challenges
11.4 Ranibizumab Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Ranibizumab Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Ranibizumab Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Ranibizumab Market Size Share by Region (2018-2024)
Table 4. Global Ranibizumab Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Ranibizumab Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Ranibizumab Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Ranibizumab Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Ranibizumab Revenue Market Share by Type (2018-2024)
Table 9. Global Ranibizumab Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Ranibizumab Revenue Market Share by Type (2024-2034)
Table 11. North America Ranibizumab Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Ranibizumab Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Ranibizumab Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Ranibizumab Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Ranibizumab Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Ranibizumab Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Ranibizumab Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Ranibizumab Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Ranibizumab Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Ranibizumab Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Ranibizumab Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Ranibizumab Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Ranibizumab Revenue Market Share by Application (2018-2024)
Table 24. Global Ranibizumab Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Ranibizumab Revenue Market Share by Application (2024-2034)
Table 26. North America Ranibizumab Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Ranibizumab Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Ranibizumab Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Ranibizumab Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Ranibizumab Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Ranibizumab Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Ranibizumab Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Ranibizumab Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Ranibizumab Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Ranibizumab Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Ranibizumab Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Ranibizumab Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ranibizumab as of 2022)
Table 39. Date of Key Players Enter into Ranibizumab Market
Table 40. Global Ranibizumab Key Players Headquarters and Area Served
Table 41. Ranibizumab Product Solution and Service
Table 42. Global Ranibizumab Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Roche Basic Information List
Table 45. Roche Description and Business Overview
Table 46. Roche Ranibizumab Products, Services and Solutions
Table 47. Revenue (US$ Million) in Ranibizumab Business of Roche (2018-2024)
Table 48. Roche Recent Developments
Table 49. Novartis Basic Information List
Table 50. Novartis Description and Business Overview
Table 51. Novartis Ranibizumab Products, Services and Solutions
Table 52. Revenue (US$ Million) in Ranibizumab Business of Novartis (2018-2024)
Table 53. Novartis Recent Developments
Table 54. North America Ranibizumab Market Size by Country (2018-2024) & (US$ Million)
Table 55. North America Ranibizumab Market Size by Country (2024-2034) & (US$ Million)
Table 56. Europe Ranibizumab Market Size by Country (2018-2024) & (US$ Million)
Table 57. Europe Ranibizumab Market Size by Country (2024-2034) & (US$ Million)
Table 58. Asia-Pacific Ranibizumab Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 59. Asia-Pacific Ranibizumab Market Size by Region (2018-2024) & (US$ Million)
Table 60. Asia-Pacific Ranibizumab Market Size by Region (2024-2034) & (US$ Million)
Table 61. Asia-Pacific Ranibizumab Market Share by Region (2018-2024)
Table 62. Asia-Pacific Ranibizumab Market Share by Region (2024-2034)
Table 63. Latin America Ranibizumab Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 64. Latin America Ranibizumab Market Size by Country (2018-2024) & (US$ Million)
Table 65. Latin America Ranibizumab Market Size by Country (2024-2034) & (US$ Million)
Table 66. Middle East & Africa Ranibizumab Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 67. Middle East & Africa Ranibizumab Market Size by Country (2018-2024) & (US$ Million)
Table 68. Middle East & Africa Ranibizumab Market Size by Country (2024-2034) & (US$ Million)
Table 69. Ranibizumab Market Trends
Table 70. Ranibizumab Market Drivers
Table 71. Ranibizumab Market Challenges
Table 72. Ranibizumab Market Restraints
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ranibizumab Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Ranibizumab Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Ranibizumab Market Share by Regions: 2022 VS 2034
Figure 4. Global Ranibizumab Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Ranibizumab Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Ranibizumab Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Ranibizumab Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Ranibizumab Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Ranibizumab Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Glass Vial
Figure 11. Global Glass Vial Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Prefilled Syringe
Figure 13. Global Prefilled Syringe Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Global Ranibizumab Market Size Share by Type: 2022 & 2034
Figure 15. North America Ranibizumab Revenue Market Share by Type (2018-2034)
Figure 16. Europe Ranibizumab Revenue Market Share by Type (2018-2034)
Figure 17. Asia-Pacific Ranibizumab Revenue Market Share by Type (2018-2034)
Figure 18. Latin America Ranibizumab Revenue Market Share by Type (2018-2034)
Figure 19. Middle East and Africa Ranibizumab Revenue Market Share by Type (2018-2034)
Figure 20. Wet AMD Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 21. Complications of Diabetes Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 22. RVO Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 23. Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 24. Global Ranibizumab Market Size Share by Application: 2022 & 2034
Figure 25. North America Ranibizumab Revenue Market Share by Application (2018-2034)
Figure 26. Europe Ranibizumab Revenue Market Share by Application (2018-2034)
Figure 27. Asia-Pacific Ranibizumab Revenue Market Share by Application (2018-2034)
Figure 28. Latin America Ranibizumab Revenue Market Share by Application (2018-2034)
Figure 29. Middle East and Africa Ranibizumab Revenue Market Share by Application (2018-2034)
Figure 30. Ranibizumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 31. Global Top 5 and Top 10 Players Ranibizumab Market Share in 2022
Figure 32. North America Ranibizumab Market Share by Country (2018-2034)
Figure 33. United States Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 34. Canada Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 35. Germany Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 36. France Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 37. U.K. Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 38. Italy Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 39. Russia Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 40. Nordic Countries Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 41. Asia-Pacific Ranibizumab Market Share by Region (2018-2034)
Figure 42. China Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 43. Japan Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 44. South Korea Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 45. Southeast Asia Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 46. India Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 47. Australia Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 48. Latin America Ranibizumab Market Share by Country (2018-2034)
Figure 49. Mexico Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 50. Brazil Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa Ranibizumab Market Share by Country (2018-2034)
Figure 52. Turkey Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 54. UAE Ranibizumab Market Size (2018-2034) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries